Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Wildiers · SciRah

Researcher profile · Semantic Scholar

J. Wildiers

Share profile

J. Wildiers — researcher profile on SciRah

h-index: 20
Works: 41
Citations: 1,800

Most-cited papers

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over.
R. Paridaens, L. Biganzoli, P. Bruning, J. Klijn +9 more
2000Journal of Clinical Oncology362 citations
Semantic Scholar
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.
J. Klijn, L. Beex, L. Mauriac, J. van Zijl +9 more
2000Journal of the National Cancer Institute249 citations Open access
Semantic Scholar
"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808).
E. Engelsman, J. Klijn, R. Rubens, J. Wildiers +4 more
1991European Journal of Cancer163 citations
Semantic Scholar
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
E. De Clercq, H. Degreef, J. Wildiers, G. de Jonge +3 more
1980British medical journal117 citations Open access
Semantic Scholar
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy.
I. Fentiman, M. Christiaens, R. Paridaens, A. V. van Geel +7 more
2003European Journal of Cancer113 citations
Semantic Scholar
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792).
R. Rubens, H. Bartelink, E. Engelsman, J. L. Hayward +7 more
1989European Journal of Cancer and Clinical Oncology90 citations
Semantic Scholar
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.
H. Harinck, O. Bijvoet, AndréS.T. Plantingh, J. Body +4 more
1987American Journal of Medicine86 citations Open access
Semantic Scholar
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
J. Schornagel, J. Verweij, P. D. de Mulder, F. Cognetti +6 more
1995Journal of Clinical Oncology74 citations Open access
Semantic Scholar
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.
J. Wildiers, E. de Clercq
1984European Journal of Cancer and Clinical Oncology59 citations
Semantic Scholar
Pigeon breeder's lung. Report of three cases.
L. Eyckmans, A. Gyselen, J. Lauwerijns, J. Cosemans +2 more
1968Diseases of the Chest57 citations
Semantic Scholar
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.
Marijke Bontenbal, Michael Andersson, J. Wildiers, G. Cocconi +7 more
1998British Journal of Cancer56 citations Open access
Semantic Scholar
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferences.
M. Nooij, J. de Haes, L. Beex, J. Wildiers +5 more
2003European Journal of Cancer55 citations
Semantic Scholar
Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck
M. Clavel, F. Cognetti, P. Dodion, J. Wildiers +8 more
1987Cancer43 citations Open access
Semantic Scholar
Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
F. Gielen, J. Dequeker, A. Drochmans, J. Wildiers +1 more
1976British Journal of Cancer43 citations Open access
Semantic Scholar
Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study.
R. Paridaens, José Thomas, J. Wildiers, P. Vermeiren +7 more
1998Anti-Cancer Drugs39 citations
Semantic Scholar
An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer.
M. Piccart, P. Bruning, J. Wildiers, A. Awada +6 more
1995Annals of Oncology33 citations Open access
Semantic Scholar
a of Assessment of bone response to systemic therapy in an trial: preliminary with the use of cross-link
J. Vinholes, R. Coleman, D. Lacombe, C. Rose +8 more
202128 citations
Semantic Scholar
Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group.
J. Verweij, P. D. de Mulder, A. de Graeff, J. Vermorken +7 more
1996Annals of Oncology23 citations
Semantic Scholar
A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer.
R. Paridaens, F. Van Aelst, V. Georgoulias, H. Samonnig +8 more
2003Annals of Oncology22 citations Open access
Semantic Scholar
A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck
J. Schornagel, J. Verweij, P. D. de Mulder, F. Cognetti +7 more
199220 citations Open access
Semantic Scholar
Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881
J. Klijn, L. Beex, L. Mauriac, J. van Zijl +7 more
199814 citations
Semantic Scholar
Oral versus intramuscular high-dose medroxyprogesterone acetate (HD-MPA) in advanced breast cancer. A randomized study of the Belgian Society of Medical Oncology.
R. Paridaens, Dominique Becquart, J. Michel, B. Vanderlinden +6 more
1986Anticancer Research10 citations
Semantic Scholar
Impact of dose-intensity of adjuvant CMF on disease-free (DFS) and overall survival (OS) in breast cancer (BC): a retrospective analysis
R. Paridaens, J. Wildiers, H. Dumez, Jose K. Thomas +6 more
20029 citations
Semantic Scholar
Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. Breast Cancer Cooperative Group.
A. V. van Oosterom, H. Mouridsen, J. Wildiers, R. Paridaens +3 more
1986European Journal of Cancer and Clinical Oncology7 citations
Semantic Scholar
Activities of the EORTC Breast Cancer Co-operative Group: an overview. [European Organization for Research and Treatment of Cancer].
J. Wildiers, K. Vantongelen, J. V. van Dongen, N. Rotmensz +1 more
1988European Journal of Cancer and Clinical Oncology6 citations
Semantic Scholar
Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU.
J. Schornagel, J. Verweij, P. D. de Mulder, J. Wildiers +2 more
1990European Journal of Cancer5 citations
Semantic Scholar
PP-8-1 Combined estroyen suppression and receptor (ER) blockade by buserelin (LHRH-A) and tamoxifen (TAM) in premenopausal metastatic breast cancer: Preliminary results of a 3-arm randomized study (EORTC 10881)
J. Klijn, C. Seynaeve, L. Beex, L. Mauriac +11 more
19964 citations
Semantic Scholar
Mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer.
J. Lemmens, P. Berteloot, José Thomas, J. Wildiers +1 more
1995European Journal of Cancer3 citations
Semantic Scholar
Locally advanced breast cancer (LABC): neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC)
W. Wynendaele, R. Paridaens, J. Wildiers, Christiaens +2 more
19991 citations
Semantic Scholar
Docetaxel is a potent cytotoxic drug in the treatment of advanced breast cancer.
W. Van Vaerenbergh, R. Paridaens, Jose K. Thomas, J. Wildiers +1 more
1998Acta Clinica Belgica1 citations
Semantic Scholar
48 Influence of concomitant radiotherapy on dose intensity of adjuvant CMF in patients with node-positive breast cancer
R. Paridaens, J. Lemmens, N. Devadder, E. van Limbergen +4 more
19951 citations
Semantic Scholar
Short versus long term treatment with CMF in posthemopausal patients with advanced breast cancer; an eortc breast cancer co-operative group phase III trial (10852)
M. A. Nogy, L. Beex, J. de Haes, J. Wildiers +5 more
19931 citations
Semantic Scholar
Phase II study of mitoxantrone in locally advanced or metastatic adenoid cystic carcinomas (ACC) of the head and neck
J. Verweij, P. D. de Mulder, A. de Graeff, J. Wildiers +5 more
19931 citations
Semantic Scholar
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
J. Schornagel, J. Verweij, P. D. de Mulder, F. Cognetti +6 more
1992Annals of Oncology1 citations
Semantic Scholar
Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861).
P. Bruning, J. M. Bonfrèr, J. Wildiers, J. Jassem +3 more
1990Journal of Steroid Biochemistry and Molecular Biology1 citations
Semantic Scholar
Acute vitamin B1 deficiency (wernicke's encephalopathy) in connection with radiotherapy for oral cavity cancer.
W. F. Van den Bogaert, J. Wildiers, E. van der Schueren, K. Ang +1 more
1981The Belgian Journal of Radiology1 citations
Semantic Scholar
EDATREXATE VERSUS METHOTREXATE IN HEAD AND NECK SCC 1651
J. Verweij, P. D. de Mulder, F. Cognetli, J. Vermorken +8 more
20190 citations
Semantic Scholar
Predictors of dose and dose intensity in adjuvant CMF with or without concomitant
H. Dumez, R. Paridaens, J. Lemmens, J. Wildiers +5 more
19990 citations
Semantic Scholar
A randomized phase II study comparing aminoglutethimide vs. trilostane vs. MPA vs. hydrocortisone: An E.O.R.T.C. study
C. Rose, H. Mouridsen, J. Wildiers, R. Paridaens +2 more
19860 citations
Semantic Scholar
The role of radiotherapy in the treatment of thyroid cancer.
W. F. Van den Bogaert, E. van der Schueren, J. Wildiers, P. Otten +4 more
1982The Belgian Journal of Radiology0 citations
Semantic Scholar
[Generalized and solitary plasmacytomas. Analysis of 55 cases].
J. Wildiers, A. Drochmans, G. Van Der Schueren
1973Revue Medicale de Liege0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Paridaens×15
Invite
R. Paridaens — researcher profile on SciRah
J. Schornagel×8
Invite
J. Schornagel — researcher profile on SciRah
J. Verweij×7
Invite
J. Verweij — researcher profile on SciRah
P. D. de Mulder×7
Invite
P. D. de Mulder — researcher profile on SciRah

×7

Invite

F. Cognetti — researcher profile on SciRah

Invite

L. Beex — researcher profile on SciRah

Invite

J. Jassem — researcher profile on SciRah

Invite

N. Rotmensz — researcher profile on SciRah

J. Vermorken×6

Invite

J. Vermorken — researcher profile on SciRah

A. V. van Oosterom×6

Invite

A. V. van Oosterom — researcher profile on SciRah

A. Kirkpatrick×6

Invite

A. Kirkpatrick — researcher profile on SciRah

W. F. Van den Bogaert×6

Invite

W. F. Van den Bogaert — researcher profile on SciRah